Specifically, there were lower rates of all-cause mortality and substantially fewer hospitalizations and emergency department visits. GLP-1 receptor agonists and dual GLP-1/GIP agonists have rapidly transformed the treatment landscape for Type 2 diabetes and obesity
When GLP-1 binds to its receptor, it amplifies the insulin signaling pathway, causing increased phosphorylation of insulin receptor substrates and activating the PI3K/Akt pathway, which ultimately results in enhanced glucose uptake, utilization within the liver, and reduced production of glucose (gluconeogenesis)
Some protocols allow up to 2 mL twice weekly for short-term metabolic intensification, though this should only be done with close medical monitoring
About the author Medical Director Aesthetic & Regenerative Medicine Leading Silk Clinics with years of experience in aesthetic medicine, Dr Ahmad Sadeqyar oversees clinical excellence across all departments and personally treats complex aesthetic cases
L-CARNITINE forms the essential transport system for use of fats as an energy source
No slouching
